971.0000 -28.10 (-2.81%)
NSE Jun 16, 2025 15:31 PM
Volume: 113.9K
 

971.00
-2.81%
BOB Capital Markets Ltd.
Q2FY25 results were below our estimates on all fronts; however, ALPM expects H2 to be better than H1FY25 driven by healthy product mix
Alembic Pharmaceutic.. has an average target of 968.25 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended